← Back to news

Markets

Argus Sees Long-Term Growth Tailwinds Building at NextEra Energy (NEE)

Y

Hexcel price target lowered to $85 from $88 at BMO Capital

Y

Verizon says right-sizing the organization, saving on OpEx

Y

Jefferies Sees Further Upside as Caterpillar’s (CAT) Broader Portfolio Gains Traction

Y

KLA Corp. price target raised to $1,751 from $1,697 at Morgan Stanley

Y

ManpowerGroup price target raised to $45 from $44 at BMO Capital

Y

Coherent price target raised to $190 from $180 at Morgan Stanley

Y

Starbucks price target raised to $120 from $115 at BMO Capital

Y

PepsiCo (PEP) Enters a New Strategic Chapter as BNP Paribas Highlights Earnings Upside

Y

Coya Therapeutics to sell 2.522M shares at $4.40 in private placement

Y

Southern Copper price target raised to $156 from $137 at Morgan Stanley

Y

IES Holdings reports Q1 adjusted EPS $3.71 vs $2.64 last year

Y

H.C. Wainwright is Bullish on TRX Gold Corporation (TRX)

Y

Roth Capital is Bullish on GoldMining Inc. (GLDG)

Y

Vista Gold Corp. (VGZ) Establishes a Goal to Begin Thorough Engineering and Design at Mt. Todd

Y

New Found Gold Corp. (NFGC) Completes Key Milestone at Queensway Gold Project by Entering into Phase 1 EPCM Contract

Y

Caledonia Mining Corporation Plc (CMCL) Raises $150 Million for Zimbabwe’s Gold Mine in a Rare International Capital Raise

Y

Seabridge Gold Inc. (SA) Released a 2025 Year-End Report

Y

Osisko Development Corp. (ODV) Announces $125M Bought Deal Offering

Y

BofA is Bullish on Aura Minerals Inc. (AUGO)

Y

Dakota Gold Corp. (DC) Announces 2026 Plans for the Richmond Hill and Maitland Gold Projects

Y

SAP price target lowered to $245 from $320 at BMO Capital

Y

Nasdaq price target raised to $116 from $113 at Morgan Stanley

Y

i-80 Gold Corp. (IAUX) Announces New High-Grade Assay Results

Y

Lumentum price target raised to $350 from $304 at Morgan Stanley

Y

Scotiabank Maintains an Outperform Rating on Gold Royalty Corp. (GROY)

Y

Dow Jones Futures: Risk-Off Market Shift, What To Do Now; Google, AMD, Amazon, Palantir Due

Y

Bitcoin Price Falling To $30,000? Influencer Predicts Collapse In Wake of Global Market Crash

Y

Trump Ally David Sacks Says US 'One Step Closer' To 'Crypto Capital' As Senate Panel Advances Bill

Y

5 Stocks To Watch Trade Near Buy Points; Three Are Data Center Plays

Y

TD Cowen Downgrades SkyWater Technology, Inc. (SKYT) to Hold After IonQ Deal

Y

Morgan Stanley Turns Bearish on Safehold Inc. (SAFE) Citing Litigation and Fee Income Risks

Y

'Overnight, my whole life changed': Cybercrime victim who lost nearly $1M and lived in poverty gets it all back and more

Y

Keefe, Bruyette & Woods Lift Esquire Financial Holdings, Inc. (ESQ) Target After In-Line Core Performance

Y

UBS Sees Higher Spending Weighing on Afya Limited (AFYA)’s Near-Term Outlook

Y

High-Grade Silver and Gold Intercepts Boost Confidence in Avino Silver & Gold Mines Ltd. (ASM)’s Growth Plan

Y

Northland Raises Innovative Aerosystems, Inc. (ISSC) Price Target to $24, Maintains Outperform on Retrofits Momentum

Y

BofA Notes Positive Interest in Novavax, Inc. (NVAX) Technology Despite Timing Concerns for Licensed Assets

Y

H.C. Wainwright Signal Clinical Data to Drive CorMedix Inc. (CRMD) Future Over Commercial Performance

Y

DA Davidson Flag Elevated Non-Performing Assets as Key Risk for Old Second Bancorp, Inc. (OSBC)

Y

Rachel Cruze Answers 8 Burning Money Questions

Y

Nvidia CEO signals investment in OpenAI round may be largest yet

Y

Citi Trims Disney (DIS) PT to $140 Ahead of Q1 Earnings and ESPN Update

Y

Cantor Fitzgerald Initiates PayPal (PYPL) Coverage with Neutral Rating and $60 PT

Y

Read This Before Buying Beyond Meat Stock

Y

Wells Fargo Maintains Overweight Rating on AT&T (T), Adjusts PT to $27

Y

Cantor Fitzgerald Raises Pfizer (PFE) PT to $27 Amid Shifting Obesity Data Focus

Y

Barclays Adjusts Elevance Health (ELV) PT to $393 While Maintaining Overweight Rating

Y

Is Apollo Global Management (APO) One of the Most Undervalued Large Cap Stocks to Invest in Now?

Y

Argus Trims CVS Health (CVS) PT to $90 Amid Medicare Advantage Rate Uncertainty

Y